Administration of antisense oligodeoxyribonucleotides targeting NF-κB prolongs allograft survival via suppression of cytotoxicity

Microsurgery

Volumn 23, Issue 5, 2003, Pages 494-497

  Chen, Zongyou ^a   Lu, Lina ^a   Zhang, Hong ^b   Dean, Nicholas M ^b   Fung, John J ^a   Qian, Shiguang ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b ISIS PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; ANTISENSE OLIGODEOXYNUCLEOTIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOSUPPRESSIVE AGENT; TRANSCRIPTION FACTOR;

ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DRUG EFFECT; DRUG TARGETING; GENE THERAPY; GENETICS; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INFUSION; MALE; METHODOLOGY; MOUSE; MOUSE STRAIN; NONHUMAN; OSMOTIC PUMP; PERITONEAL CAVITY; PHYSIOLOGY; PRIORITY JOURNAL;

ANIMALS; GENE THERAPY; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOSUPPRESSIVE AGENTS; INFUSIONS, PARENTERAL; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MODELS, ANIMAL; NF-KAPPA B; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0142151563     PISSN: 07381085     EISSN: None     Source Type: Journal    
DOI: 10.1002/micr.10182     Document Type: Conference Paper

References (24)

1. Salomon B, Bluestone JA. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol 2001;19:225-252.
2. Kishimoto K, Dong VM, Sayegh MH. The role of costimulatory molecules as targets for new immunosuppressives in transplantation. Curr Opin Urol 2000;10:57-62.
3. Thanos D, Maniatis T. NF-κB: a lesson in family values. Cell 1995;80:532-592.
4. May MJ, Ghosh S. Signal transduction through NF-κB. Immunol Today 1998;19:80-88.
5. Rescigno M, Martino M, Sutherland CL, Gold MR, Ricciardi-Castagnoli P. Dendritic cell survival and maturation are regulated by different signaling pathways. J Exp Med 1998;188:2175-2180.
6. Ghosh S, May MJ, Kopp EB. NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998;16:225-234.
7. Pahl HL. Activators and target genes of Rel/NF-κB transcription factors. Oncogene 1999;18:6853-6861.
8. Karras JG, McGraw K, McKay RA, Cooper SR, Lerner D, Lu T, Walker C, Dean NM, Monia BP. Inhibition of antigen-induced eosinophilia and late phase airway hyperresponsiveness by an IL-5 antisense oligonucleotide in mouse models of asthma. J Immunol 2000;164:5409-5415.
9. English J, Evan A, Houghton DC, Bennett WM. Cyclosporine-induced acute renal dysfunction in the rat. Evidence of arteriolar vasoconstriction with preservation of tubular function. Transplantation 1987;44:135-141.
10. Fleiss JL. Statistical methods for rates and proportions. 2nd ed. New York: Wiley; 1981. 44 p.
11. Mirabelli CK, Crooke ST. Antisense research and applications. In: Antisense Research and Applications Crooke ST, Lebleu B, editors. Boca Raton, FL: CRC Press; 1993. p 579.
12. Solez K, Vincenti F, Filo RS. Histopathologic findings from 2-year protocol biopsies from a US multicenter kidney transplant trial comparing tacrolimus versus cyclosporine: a report of the FK506 kidney transplant study group. Transplantation 1998;66:1736-1742.
13. Crooke ST. Therapeutic applications of oligonucleotides. Annu Rev Pharmacol Toxicol 1992;32:329-338.
14. Hoke GD, Draper K, Freier SM, Gonzalez C, Driver VB, Zounes MC, Ecker DJ. Effects of phosphorothioate capping on antisense oligonucleotide stability, hybridization and antiviral efficacy versus herpes simplex virus infection. Nucleic Acids Res 1991;19:5743-5753.
15. Yu RZ, Zhang H, Geary RS, Graham M, Masarjian L, Lemonidis K, Crooke R, Dean NM, Levin AA. Pharmacokinetics and pharmacodynamics of an antisense phosphorothioate oligonucleotide targeting Fas mRNA in mice. J Pharmacol Exp Ther 2001;296:388-395.
16. Zhang H, Cook J, Nickel J, Yu R, Stecker K, Myers K, Dean NM. Reduction of liver Fas expression by an antisense oligonucleotide protects mice from fulminant hepatitis. Nat Biotechnol 2000;18:862-867.
17. Butler M, Mckay RA, Popoff IJ, Gaarde WA, Witchell D, Murray SF, Dean NM, Bhanot S, Monia BP. Specific inhibition of PTEN expression reverses hyperglycemia in diabetic mice. Diabetes 2002;51:1028-1034.
18. Vickers T, Baker BF, Cook PD, Zounes M, Buckheit RW Jr, Germany J, Ecker DJ. Inhibition of HIV-LTR gene expression by oligonucleotides targeted to the TAR element. Nucleic Acids Res 1991;19:3359-3368.
19. Corry RJ, Winn HJ, Russell PS. Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 1973;16:343-350.
20. Rescigno M, Martino M, Sutherland CL, Gold MR, Ricciardi-Castagnoli P. Dendritic cell survival and maturation are regulated by different signaling pathways. J Exp Med 1998;188:2175-2180.
21. Weih F, Carrasco D, Durham SK, Barton DS, Rizzo CA, Ryseck RP, Lira SA, Bravo R. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family. Cell 1995;80:331-340.
22. + dendritic cells. Immunity 1998;9:839-847.
23. Thanos D, Maniatis T. NF-κB: a lesson in family values. Cell 1995;80:592-532.
24. May MJ, Ghosh S. Signal transduction through NF-κB. Immunol Today 1998;19:80-88.